Page last updated: 2024-10-28

lidocaine and Bright Disease

lidocaine has been researched along with Bright Disease in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research Excerpts

ExcerptRelevanceReference
"Lidocaine was effective in 26 patients and 16 (63%) of these had their arrhythmias controlled with tocainide."1.26Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success. ( Harrison, DC; Mason, JW; Winkle, RA, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winkle, RA1
Mason, JW1
Harrison, DC1

Other Studies

1 other study available for lidocaine and Bright Disease

ArticleYear
Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    American heart journal, 1980, Volume: 100, Issue:6 Pt 2

    Topics: Aged; Anilides; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Humans; Lidocaine; Mal

1980